Skip header and navigation

Refine By

105 records – page 1 of 11.

Ampicillin in the treatment of imprisoned patients with gonorrhoea.

https://arctichealth.org/en/permalink/ahliterature254594
Source
Br J Vener Dis. 1973 Jun;49(3):271-3
Publication Type
Article
Date
Jun-1973
Author
T. Jersild
T L Svendsen
Source
Br J Vener Dis. 1973 Jun;49(3):271-3
Date
Jun-1973
Language
English
Publication Type
Article
Keywords
Administration, Oral
Ampicillin - administration & dosage - therapeutic use
Denmark
Female
Gonorrhea - drug therapy
Humans
Male
Penicillin G - therapeutic use
Prisoners
Prisons
Notes
Cites: Br J Vener Dis. 1969 Jun;45(2):144-85787685
Cites: Br J Vener Dis. 1963 Dec;39:225-714086506
Cites: Ugeskr Laeger. 1971 Jul 2;133(26):1253-64998020
Cites: Br J Vener Dis. 1969 Sep;45(3):235-75346421
PubMed ID
4719161 View in PubMed
Less detail

An epidemic due to sulphonamide-resistant group A meningococci in the Helsinki area (Finland). Epidemiological and clinical observations.

https://arctichealth.org/en/permalink/ahliterature251584
Source
Scand J Infect Dis. 1976;8(4):249-54
Publication Type
Article
Date
1976
Author
I. Salmi
O. Pettay
I. Simula
A K Kallio
O. Waltimo
Source
Scand J Infect Dis. 1976;8(4):249-54
Date
1976
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Age Factors
Arthritis - etiology
Child
Child, Preschool
Female
Finland
Humans
Infant
Male
Meningococcal Infections - drug therapy - epidemiology - genetics
Middle Aged
Neisseria meningitidis
Penicillin G - therapeutic use
Penicillin resistance
Prognosis
Seasons
Sex Factors
Sulfonamides
Abstract
An epidemic due to sulphonamide-resistant group A meningococci started in Finland in January 1973. By the end of 1974 the number of cases exceeded 1300. This report describes epidemiological and clinical observations in 370 patients treated in Helsinki 1973-1974. The incidence was about 65 per 100 000 per year in children under 7 years of age and about 10 per 100 000 in adults. More than one case occurred in 3.8% of the families and in 36% of the lodging-houses of the lowest social group. The fatality rate of patients treated in hospital was 4.1%. Persistent neurological damage was noticed in 4.6%.
PubMed ID
827013 View in PubMed
Less detail
Source
Int J STD AIDS. 2002 Jun;13(6):370-2
Publication Type
Article
Date
Jun-2002
Author
A M Halsos
K. Edgardh
Author Affiliation
Department of STD (The Olafia Clinic), Ullevål University Hospital, Grensen 5-7, 0159 Oslo, Norway.
Source
Int J STD AIDS. 2002 Jun;13(6):370-2
Date
Jun-2002
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Disease Outbreaks
Female
Homosexuality, Male
Humans
Male
Middle Aged
Norway - epidemiology
Penicillin G - therapeutic use
Penicillins - therapeutic use
Retrospective Studies
Risk-Taking
Sexual Behavior
Syphilis - drug therapy - epidemiology
Abstract
During 1999 and 2000, an outbreak of syphilis occurred in Norway: 93 cases were reported to the National Institute of Public Health. This report summarizes a retrospective investigation of the medical records of 60 patients with primary, secondary and early latent syphilis treated during 1999-2000 at the Department of STD at the Ullevål University Hospital in Oslo. Five women and 55 men were treated, mean age 38.6 and 44.9 years, respectively. Of the 60 cases, 14 (23.3%) had primary, 39 (65.0) secondary and seven (11.7%) early latent syphilis. Men who have sex with men (MSM) constituted 78.2% (43/55) of the male patients. Transmission among MSM was related to casual sexual contacts in bathhouses in Oslo. Two cases occurred among men with previously diagnosed HIV infection. Two new cases of HIV were reported. Condom use was inconsistent, and seldom used for oral sex.
PubMed ID
12015009 View in PubMed
Less detail

Antibiotic abuse: the testimony of medical students.

https://arctichealth.org/en/permalink/ahliterature252153
Source
Can Med Assoc J. 1975 Jun 21;112(12):1428-9
Publication Type
Article
Date
Jun-21-1975
Author
T L Perry
Source
Can Med Assoc J. 1975 Jun 21;112(12):1428-9
Date
Jun-21-1975
Language
English
Publication Type
Article
Keywords
Ampicillin - therapeutic use
Anti-Infective Agents - therapeutic use
Bacterial Infections - diagnosis - drug therapy
British Columbia
Clindamycin - therapeutic use
Cloxacillin - therapeutic use
Education, Medical, Undergraduate
Erythromycin - therapeutic use
Humans
Neomycin - therapeutic use
Penicillin G - therapeutic use
Penicillin resistance
Penicillin V - therapeutic use
Student Health Services - standards
Students, Medical
Substance-Related Disorders - epidemiology
Sulfonamides - therapeutic use
Tetracycline - therapeutic use
Abstract
Surveys of the use of antimicrobial drugs on students during antimicrobial drugs on students during their first 15 months in medical or dental school indicate that they have been treated with these agents at least three times as frequently as seems reasonable, and that the tetracyclines, ampicillin, penicillin G and erythromycin are the chief drugs overused. Antimicrobiol therapy is frequently instituted for probable viral respiratory tract infections and without any attempt to establish a bacteriologic diagnosis. It is likely that anitmicrobiol agents are used more widely in treating the general public in Canada than in treating medical students. Improvements in the rational use of this important group of drugs could increase the quality and probably reduced the cost of medical care.
Notes
Cites: Can Med Assoc J. 1967 Dec 9;97(24):1445-506061608
Cites: JAMA. 1974 Mar 4;227(9):1023-84405926
Cites: N Engl J Med. 1971 Jun 17;284(24):1361-84930604
Cites: Ann Intern Med. 1973 Oct;79(4):555-604795880
Cites: Lancet. 1974 Feb 23;1(7852):3134130492
Cites: J Infect Dis. 1974 Aug;130(2):165-84842338
Cites: N Engl J Med. 1974 Oct 3;291(14):733-44851512
Cites: N Engl J Med. 1972 Aug 10;287(6):261-75038951
Cites: J Infect Dis. 1969 Jun;119(6):662-55795107
PubMed ID
806341 View in PubMed
Less detail

Antibiotic resistance patterns among blood culture isolates in a Danish county 1981-1995.

https://arctichealth.org/en/permalink/ahliterature203319
Source
J Med Microbiol. 1999 Jan;48(1):67-71
Publication Type
Article
Date
Jan-1999
Author
B. Kristensen
H H Smedegaard
H M Pedersen
M F Andersen
J F Dahlerup
H T Sørensen
B. Korsager
H C Schønheyder
Author Affiliation
Department of Clinical Microbiology, Aalborg Hospital, Denmark.
Source
J Med Microbiol. 1999 Jan;48(1):67-71
Date
Jan-1999
Language
English
Publication Type
Article
Keywords
Aminoglycosides
Ampicillin - therapeutic use
Anti-Bacterial Agents - therapeutic use
Bacteremia - drug therapy - epidemiology - microbiology
Denmark - epidemiology
Drug Resistance, Microbial
Drug Resistance, Multiple
Drug Therapy, Combination - therapeutic use
Escherichia coli - drug effects - isolation & purification
Gram-Negative Bacteria - drug effects - isolation & purification
Gram-Negative Bacterial Infections - drug therapy - microbiology
Gram-Positive Bacteria - drug effects - isolation & purification
Gram-Positive Bacterial Infections - drug therapy - microbiology
Humans
Penicillin G - therapeutic use
Abstract
All episodes of bacteraemia during a 15-year period (1981-1995) in the County of Northern Jutland, Denmark, were analysed with regard to antibiotic resistance. A total of 8840 isolates from 7938 episodes of bacteraemia was identified. Over time, no changes in bacterial aetiology were noted. Three isolates of Staphylococcus aureus were methicillin resistant (0.2%) and six were gentamicin resistant (0.4%). Among coagulase-negative staphylococci a 14% increase in resistance to penicillin was observed (95% confidence intervals, CI: 2-26%). Likewise, the frequency of resistance to methicillin, gentamicin and erythromycin increased, the corresponding figures being 38% (CI: 26-50%), 26% (CI: 14-38%) and 32% (CI: 16-50%), respectively, whereas a 14% decrease in resistance to streptomycin was recorded (CI: 4-24%). A 20% (CI: 2-37%) increase of coagulase-negative staphylococci resistant to three or more antibiotics was observed. The frequency of ampicillin resistance increased by 9% among Escherichia coli (CI: 4-13%) and by 10% (CI: 6-14%) in all Enterobacteriaceae. Among Enterobacteriaceae the level of resistance to third-generation cephalosporins, carbapenems, aminoglycosides and fluoroquinolones remained low (
PubMed ID
9920127 View in PubMed
Less detail

Antibiotic sensitivities of Neisseria gonorrhoeae in the Toronto area.

https://arctichealth.org/en/permalink/ahliterature253345
Source
Can Med Assoc J. 1974 Jul 6;111(1):44-6
Publication Type
Article
Date
Jul-6-1974
Author
K F Givan
A. Keyl
Source
Can Med Assoc J. 1974 Jul 6;111(1):44-6
Date
Jul-6-1974
Language
English
Publication Type
Article
Keywords
Anti-Bacterial Agents - pharmacology
Cephaloridine - pharmacology
Erythromycin - pharmacology
Female
Gonorrhea - drug therapy - microbiology
Humans
Male
Microbial Sensitivity Tests
Neisseria gonorrhoeae - drug effects - isolation & purification
Ontario
Penicillin G Procaine - therapeutic use
Penicillin resistance
Spectinomycin - pharmacology - therapeutic use
Tetracycline - pharmacology - therapeutic use
Abstract
The antibiotic sensitivity pattern of 3872 isolates of N. gonorrhoeae tested in Toronto from 1969 to 1973 is reviewed. An increase in resistance to both penicillin and tetracycline was noted up to 1971, but no further increase has occurred since then. Ninety-seven percent of 135 patients with "sensitive" strains (inhibited by 0.3 U/ml of penicillin and/or 0.5 mug/ml of tetracycline) were cured by either 8 g of tetracycline or 5,000,000 U of penicillin, whereas only 59% of 58 patients with "resistant" strains (requiring 1.0 U/ml of penicillin and/or 2.0 mug/ml of tetracycline for inhibition) were cured by the same dosage. Spectinomycin appears to be an acceptable alternative therapy. Maximum doses of the chosen drug are recommended in the hope of retarding further spread of more resistant organisms.
Notes
Cites: Can Med Assoc J. 1963 Sep 21;89:601-614063939
Cites: Can Med Assoc J. 1972 Nov 18;107(10):959-624628259
Cites: Can J Public Health. 1967 Jul;58(7):296-3004859908
Cites: Antimicrob Agents Chemother (Bethesda). 1968;8:431-44980838
Cites: Br J Vener Dis. 1970 Aug;46(4):330-35470081
Cites: Med Clin North Am. 1972 Sep;56(5):1133-444262305
Cites: Br J Vener Dis. 1972 Jun;48(3):163-764560724
Cites: J Infect Dis. 1973 Apr;127(4):461-64632883
PubMed ID
4276273 View in PubMed
Less detail

Antibiotic susceptibility pattern and capsular types of Haemophilus influenzae recovered from clinical specimens in northern Norway.

https://arctichealth.org/en/permalink/ahliterature12847
Source
Acta Pathol Microbiol Immunol Scand [B]. 1983 Dec;91(6):383-7
Publication Type
Article
Date
Dec-1983
Author
K. Melby
T. Leinslie
N. Hagen
L H Vorland
Source
Acta Pathol Microbiol Immunol Scand [B]. 1983 Dec;91(6):383-7
Date
Dec-1983
Language
English
Publication Type
Article
Keywords
Ampicillin - pharmacology
Anti-Bacterial Agents - pharmacology
Chloramphenicol - pharmacology
Haemophilus Infections - microbiology
Haemophilus influenzae - classification - drug effects
Humans
Norway
Penicillin G - pharmacology
Penicillin V - pharmacology
Plasmids
Polysaccharides, Bacterial - classification
Research Support, Non-U.S. Gov't
Sulfisomidine - pharmacology
Sulfonamides - pharmacology
beta-Lactamases - metabolism
Abstract
One hundred and nine strains of Haemophilus influenzae recovered from clinical specimens were examined for antibiotic sensitivity pattern and capsular types. All strains from blood cultures, cerebrospinal fluid and a joint aspirate were type b whereas most of the isolates were acapsular when recovered from other specimens viz. wound secretions (67%), maxillary sinus (75%), lower resp tract (86%), nasal cavity (90%). Out of the 109 strains 88 (81%) were non-typable, and 3.6% were beta-lactamase-producing, two of which were type e, one was type b and one was acapsular. Three beta-lactamase-producing strains were isolated from specimens from the respiratory tract and one from blood cultures. Beta-lactamase-producing strains including one chloramphenicol-resistant strain harboured similar plasmids, as judged by agarose gel electrophoresis. The strains showed quite a uniform sensitivity to antibacterial agents with the exception of sulphonamides to which the capsular strains, particularly type b strains, were less susceptible.
PubMed ID
6424404 View in PubMed
Less detail

[Antibiotic treatment of women with group B Steptococci during delivery?]

https://arctichealth.org/en/permalink/ahliterature90709
Source
Tidsskr Nor Laegeforen. 2008 Nov 6;128(21):2467-9
Publication Type
Article
Date
Nov-6-2008
Author
Kløvstad Hilde
Høiby E Arne
Aavitsland Preben
Author Affiliation
Avdeling for infeksjonsovervåking Nasjonalt folkehelseinstitutt Postboks 4404 Nydalen 0403 Oslo. hilde.klovstad@fhi.no
Source
Tidsskr Nor Laegeforen. 2008 Nov 6;128(21):2467-9
Date
Nov-6-2008
Language
Norwegian
Publication Type
Article
Keywords
Anti-Bacterial Agents - administration & dosage - adverse effects
Carrier State - microbiology
Delivery, Obstetric
Drug Resistance, Bacterial
Drug Utilization Review
Female
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical - prevention & control
Penicillin G - administration & dosage - adverse effects
Pregnancy
Pregnancy Complications, Infectious - drug therapy - microbiology
Streptococcal Infections - prevention & control - transmission
Streptococcus agalactiae - isolation & purification
Abstract
BACKGROUND: Transmission of group B Steptococci from mother to child during delivery may cause serious disease in some children, but this can be prevented by use of antibiotic treatment during delivery. We have estimated how antibiotic treatment of all pregnant carriers of group B streptococcus during delivery would affect the total antibiotic use in Norway. MATERIAL AND METHODS: We estimated the use of penicillin G for treatment of 10 %, 20 % and 30 % of streptococcus carriers among those delivering. The Medical Birth Registry was used to obtain number of births and the Norwegian Drug Wholesalers Database to obtain total use of the various substances. RESULTS: If 30 % of delivering women were carriers of group B streptococcus and treated with penicillin G, the treatment would equal 2.8 % of today's total use of penicillin G and 0.09 % of the total use of the whole group of beta-lactam antibacterial agents, penicillins. INTERPRETATION: Prophylactic antibiotic treatment of pregnant carriers of group B streptococcus during delivery would not lead to a substantial change in the current antibiotic use. The possibility of increasing antibiotic resistance should not be a main argument against using antibiotics in prevention of group B streptococcus infection in newborns.
PubMed ID
19096471 View in PubMed
Less detail

105 records – page 1 of 11.